Gene and advanced cell therapies are medicines built from genes, substantially manipulated cells or engineered tissue, regulated more tightly than any other orthobiologic.
They are the most heavily regulated interventions a sport and exercise medicine (SEM) clinician is likely to be asked about, and they have transformed care in a small number of serious conditions. In musculoskeletal practice their established role is narrow, and they are often misrepresented in marketing.
The clinician needs 3 things: what these therapies are and how they differ from other orthobiologics, how they are regulated as advanced therapy medicinal products (ATMPs), and how they meet anti-doping rules, since gene and cell doping is a prohibited method in its own right.
Unlock 10 full topics of your choice with a free account.
Already have an account? Log in